These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38695781)

  • 1. Fear, defense, and emotion: A neuroethological understanding of the negative valence research domain criteria.
    Fanselow MS; Hoffman AN
    Am Psychol; 2024; 79(5):725-734. PubMed ID: 38695781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of Threat Responses Within the Negative Valence Framework.
    Smith NJ; Markowitz SY; Hoffman AN; Fanselow MS
    Front Syst Neurosci; 2022; 16():886771. PubMed ID: 35694043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative valence systems: sustained threat and the predatory imminence continuum.
    Fanselow MS
    Emerg Top Life Sci; 2022 Dec; 6(5):467-477. PubMed ID: 36286244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety, fear, panic: An approach to assessing the defensive behavior system across the predatory imminence continuum.
    Hoffman AN; Trott JM; Makridis A; Fanselow MS
    Learn Behav; 2022 Sep; 50(3):339-348. PubMed ID: 35112315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-report indicators of negative valence constructs within the research domain criteria (RDoC): A critical review.
    Watson D; Stanton K; Clark LA
    J Affect Disord; 2017 Jul; 216():58-69. PubMed ID: 27823854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Examination of the RDoC Negative Valence Systems Domain Constructs and the Self-Reports Unit of Analysis.
    Hasratian AM; Meuret AE; Chmielewski M; Ritz T
    Behav Ther; 2022 Nov; 53(6):1092-1108. PubMed ID: 36229109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobehavioral perspectives on the distinction between fear and anxiety.
    Perusini JN; Fanselow MS
    Learn Mem; 2015 Sep; 22(9):417-25. PubMed ID: 26286652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six Years of Research on the National Institute of Mental Health's Research Domain Criteria (RDoC) Initiative: A Systematic Review.
    Carcone D; Ruocco AC
    Front Cell Neurosci; 2017; 11():46. PubMed ID: 28316565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and environment in the National Institute of Mental Health (NIMH) Research Domain Criteria.
    Sanislow CA; Morris SE; Cuthbert BN; Pacheco J
    J Psychopathol Clin Sci; 2022 Aug; 131(6):653-659. PubMed ID: 35901394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric assessment of Research Domain Criteria positive and negative valence systems: Partial genetic mediation of links to problem behaviors.
    Moore MN; Planalp EM; Van Hulle CA; Goldsmith HH
    J Psychopathol Clin Sci; 2022 Aug; 131(6):626-640. PubMed ID: 35901392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Applications of the National Institute of Mental Health's Research Domain Criteria (RDoC) to Clinical Psychiatric Practice: How RDoC Might Be Used in Assessment, Diagnostic Processes, Case Formulation, Treatment Planning, and Clinical Notes.
    Yager J; Feinstein RE
    J Clin Psychiatry; 2017 Apr; 78(4):423-432. PubMed ID: 28002661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood and anxiety disorders within the Research Domain Criteria framework of Positive and Negative Valence Systems: a scoping review.
    Böttger SJ; Förstner BR; Szalek L; Koller-Schlaud K; Rapp MA; Tschorn M
    Front Hum Neurosci; 2023; 17():1184978. PubMed ID: 37333832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.
    Pouyan N; Younesi Sisi F; Kargar A; Scheidegger M; McIntyre RS; Morrow JD
    CNS Drugs; 2023 Dec; 37(12):1027-1063. PubMed ID: 37999867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding anxiety symptoms as aberrant defensive responding along the threat imminence continuum.
    Abend R
    Neurosci Biobehav Rev; 2023 Sep; 152():105305. PubMed ID: 37414377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Learning in Threat Imminence and Defensive Behaviors.
    Fanselow MS
    Curr Opin Behav Sci; 2018 Dec; 24():44-49. PubMed ID: 30276224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain.
    Hui A
    PLoS One; 2020; 15(12):e0243057. PubMed ID: 33326436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human connectome project for disordered emotional states: Protocol and rationale for a research domain criteria study of brain connectivity in young adult anxiety and depression.
    Tozzi L; Staveland B; Holt-Gosselin B; Chesnut M; Chang SE; Choi D; Shiner M; Wu H; Lerma-Usabiaga G; Sporns O; Barch DM; Gotlib IH; Hastie TJ; Kerr AB; Poldrack RA; Wandell BA; Wintermark M; Williams LM
    Neuroimage; 2020 Jul; 214():116715. PubMed ID: 32147367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the Research Domain Criteria project for childhood anxiety and its disorders.
    Lebowitz ER; Gee DG; Pine DS; Silverman WK
    Clin Psychol Rev; 2018 Aug; 64():99-109. PubMed ID: 29526524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA neurons of the ventral periaqueductal gray area modulate behaviors associated with anxiety and conditioned fear.
    Lowery-Gionta EG; DiBerto J; Mazzone CM; Kash TL
    Brain Struct Funct; 2018 Nov; 223(8):3787-3799. PubMed ID: 30076467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression ("RAD") project.
    Williams LM; Goldstein-Piekarski AN; Chowdhry N; Grisanzio KA; Haug NA; Samara Z; Etkin A; O'Hara R; Schatzberg AF; Suppes T; Yesavage J
    BMC Psychiatry; 2016 Mar; 16():68. PubMed ID: 26980207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.